*Apple shares sink after Carl Icahn comments. "This really personifies how important central bank policy is on the market," said Jack Ablin, chief investment officer at BMO Private Bank. Jude Medical soared 26.3 percent to $78.22 after Abbott Laboratories said it agreed to buy the medical device maker for $25 billion. » Read More
Jan 8- Breast implant maker Sientra Inc said its medical implants were found to be safe during a third-party testing, three months after it suspended sales of the devices to ensure technical compliance. In a letter to plastic surgeons dated Thursday, Chief Executive Jeffrey Nugent said the regulatory bodies had reviewed the device and found it to be safe and...
The recent criticism surrounding $9 billion diagnostics firm Theranos has been unfair, Theranos board member Richard Kovacevich tells CNBC.
Over the past several years, the FDA has received thousands of reports of complications, including bleeding, organ perforation and urinary problems, involving the use of mesh for transvaginal POP repair, the agency said. The FDA noted that an advisory panel of experts in 2011 recommended that more data was needed to establish their safety.
China's capital Beijing issued its second smog red alert of the month on Friday, triggering vehicle restrictions and forcing schools to close.
Dec 3- Medical device maker Medtronic Plc reported a better-than-expected quarterly profit, helped by higher sales in all divisions. The Dublin- based company said adjusted profit per share included a 4- cent charge from integrating Covidien Plc, which Medtronic bought in January for nearly $50 billion. Medtronic said its net profit fell to $520 million, or 36...
Dec 3- Medical device maker Medtronic Plc reported a 62 percent jump in quarterly revenue, helped by higher sales in all divisions. The Dublin- based company's net profit fell to $520 million, or 36 cents per share, in the second quarter ended Oct. 30 from $828 million, or 83 cents per share, a year earlier, mainly due to higher restructuring charges.
Medtronic Plc, Abbott Laboratories, Edwards Lifesciences Corp and HeartWare International Inc in recent months have spent a total of $2 billion to buy young companies developing versions of the technology. Nearly 6 million people in the United States may suffer from mitral disease, and Wall Street analysts say it could be the next multibillion-dollar...
Rising demand for IVF in China will strain already-crowded state-run hospitals but create opportunities for overseas health centers.
PARIS, Nov 13- French medical technology company Mauna Kea could sign a partnership by the end of the year that would allow it to accelerate the commercial development of a small microscope approved by U.S. regulators for use in surgical procedures to diagnose cancer, its chief executive told Reuters. According to Mauna Kea, the use of Cellvizio in surgery would...
In its letter, posted on Monday, the agency said it was unable to identify any FDA clearance for the company's test. In a statement sent to Reuters last week, FDA spokesman Eric Pahon said the FDA believes that "certain types of tests are being appropriately offered through the DTC model, but others may need to demonstrate that they are safe and effective and that...
Nov 6- Indiana- based medical device manufacturer Zimmer Biomet Holdings Inc on Friday was cleared of liability in the first of more than 900 U.S. lawsuits to go to trial over claims that its NexGen Flex knee replacements were prone to painful, motion-impairing loosening. Following a three-week trial in the U.S. District Court for the Northern District of...
Theranos only uses its finger-prick technology in one test after pressure from regulators, The WSJ reports.
As baby boomers age, UPS, FedEx and DHL expect health-care logistics to become a more important part of their future.
Teen creates cheaper way to test for Ebola
Reckitt Benckiser, the maker of Durex condoms, is calling on India to axe price controls on its products, the FT reports.
These wearables can read your mind and mood. Companies like Interaxon, Thync and Scanadu are leveraging EEG sensors to help users control their thoughts.
Mount Sinai's CEO sees a "death spiral" could occur if the Supreme Court rules against the health insurance subsidies in Obamacare.
Bad news has been a boon for Malaysia's rubber glove makers, with the ringgit's drop and South Korea's MERS outbreak likely to provide a twin boost.
The health-care sector is hot, and investors don't have to bet on the riskiest biotech stocks to profit.
John Hancock aims to use wearables to track policyholders' activity, using the information to provide differential pricing on insurance policies.